AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMPAGLIFLOZIN+LINAGLIPTIN
16 registrations across 5 African markets— 15 active
Markets with EMPAGLIFLOZIN+LINAGLIPTIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| EMPAGOOD 25 L Tablet | 🇰🇪Kenya | ZAIN PHARMA LIMITED | active | Dec 2030 |
| Empazin-L 25mg/5mg Tablet Tablet | 🇰🇪Kenya | Pharmatec Pakistan (Pvt.) Ltd | active | Aug 2030 |
| Empazin-L 10mg/5mg Tablet Tablet | 🇰🇪Kenya | Pharmatec Pakistan (Pvt.) Ltd | active | Aug 2030 |
| Empiget LT Tablets 25 mg + 5 mg** Tablet | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Jun 2029 |
| Empiget LT Tablet 10 mg + 5 mg** Tablet | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | May 2029 |
| Empiget-LT Tablets 25mg+5mg Film-Coated Tablet | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Nov 2028 |
| Empiget-LT Tablets 10mg+5mg Film-Coated Tablet | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Nov 2028 |
| Glympa 10/5 Tablet Tablet | 🇰🇪Kenya | Square Pharmaceuticals Ltd. | active | Apr 2028 |
| Glympa 25/5 Tablet Tablet | 🇰🇪Kenya | Square Pharmaceuticals Ltd. | active | Apr 2028 |
| GLYXAMBI 10/5 mg | 🇿🇦South Africa | Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale | active | Oct 2027 |
| GLYXAMBI 25/5 mg | 🇿🇦South Africa | Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale | active | Oct 2027 |
| GLYXAMBI 25MG/5MG TABLETS | 🇬🇭Ghana | — | active | Mar 2027 |
| GLYXAMBI 10MG/5MG TABLETS (Each film-coated tablet contains Empagliflozin/ Linagliptin 10/5mg) | 🇬🇭Ghana | — | active | Mar 2027 |
| GLYXAMBI 25MG/5MG TABLETS | 🇬🇭Ghana | — | active | Mar 2027 |
| GLYXAMBI 10MG/5MG TABLETS (Each film-coated tablet contains Empagliflozin/ Linagliptin 10/5mg) | 🇬🇭Ghana | — | active | Mar 2027 |
| ZIMPALIN 10MG/ 5MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | PINNACLE LIFE SCIENCE PVT.LTD | expired | Oct 2024 |
EMPAGLIFLOZIN+LINAGLIPTIN in Africa — Regulatory Overview
EMPAGLIFLOZIN+LINAGLIPTIN is registered across 5 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Ghana, Nigeria, South Africa and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 16 registrations, 15 (94%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.